Pembrolizumab for Bladder Cancer User Reviews
Brand names: Keytruda
- bob
- Taken for 1 to 6 months
- March 8, 2024
Keytruda (pembrolizumab) "3 months treating so far. Side effects: fatigue, lower GI disturbances, some flares for pseudo gout."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Bladder Cancer
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about pembrolizumab
- Check interactions
- Compare alternatives
- Reviews (232)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Keytruda (pembrolizumab) "I am experiencing numbness in my hands and feet, muscle pain in my shoulders, legs, and hips. These pains are worse in the AM and subside as the day progresses. The swelling and numbness in my ankles and feet usually happen late at night, before night."